Use of calcium sensing receptor antagonists for treating ocular disorders
OwnerOnur CIL, Neel PASRICHAinventors
Life of this patent
Estimating the term…
Abstract
Disclosed herein include therapy for treating ocular disorders such as dry eye disease by targeting calcium sensitive receptor (CaSR), a regulator of ocular surface ion transport.
Claims15
A method for treating ocular surface disorders in a subject in need thereof, the method comprising administrating to the subject a pharmaceutical composition comprising a calcium sensitive receptor (CaSR) antagonist and an ophthalmically acceptable excipient.
A method for increasing tear production in a subject in need thereof, the method comprising administrating to the subject a pharmaceutical composition comprising a calcium sensitive receptor (CaSR) antagonist and an ophthalmically acceptable excipient.
A topical ophthalmic formulation for use in treating ocular surface disorders or increasing tear production, the ophthalmic formulation comprising a calcium sensitive receptor (CaSR) antagonist and an ophthalmically acceptable excipient.
Dependencies are inferred from the claim text.